ClearBridge Investments - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 5 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2020$4,000
+100.0%
1,0000.0%0.00%
Q1 2020$2,0000.0%1,0000.0%0.00%
Q4 2019$2,0000.0%1,0000.0%0.00%
Q3 2019$2,000
+100.0%
1,0000.0%0.00%
Q2 2019$1,000
-50.0%
1,0000.0%0.00%
Q1 2019$2,000
+100.0%
1,0000.0%0.00%
Q4 2018$1,000
-50.0%
1,0000.0%0.00%
Q3 2018$2,000
-33.3%
1,0000.0%0.00%
Q2 2018$3,000
-25.0%
1,0000.0%0.00%
Q1 2018$4,000
+33.3%
1,0000.0%0.00%
Q4 2017$3,000
-25.0%
1,0000.0%0.00%
Q3 2017$4,0000.0%1,0000.0%0.00%
Q2 2017$4,0000.0%1,0000.0%0.00%
Q1 2017$4,000
+33.3%
1,0000.0%0.00%
Q4 2016$3,0000.0%1,0000.0%0.00%
Q3 2016$3,0000.0%1,0000.0%0.00%
Q2 2016$3,000
+50.0%
1,0000.0%0.00%
Q1 2016$2,000
-33.3%
1,0000.0%0.00%
Q4 2015$3,0001,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders